Images List Premium Download Classic

Vasocon

Vasocon-related patent applications - as published by the U.S. Patent and Trademark Office (USPTO).


loading
Therapeutic room thermostat
October 19, 2017 - N°20170296378

The purpose of the disclosed thermostat is to prevent age-related diseases, induced by long term cool indoor temperatures. As people age, the body produces progressively less heat while aging-impaired vasoconstriction results in progressively more heat being lost. This age-induced cold stress requires ever greater use of vasoconstriction or behavior to maintain the body's heat balance. When behavioral regulation becomes diminished ...
Iglass: infrared thermography for learning thermoregulation performance
University Of Southern California
September 21, 2017 - N°20170265755

An infrared thermography based technique is described for monitoring an individual's thermoregulation performance and thermal comfort level through measuring the skin temperature on several points the face as the face has a high density of blood vessels and it is typically not covered by clothing. This technique allows for continuous monitoring during normal daily activities and instantaneous identification of thermoregulation ...
Arthroscopic irrigation solution and method for peripheral vasoconstriction and inhibition of pain and inflammation
Omeros Corporation
August 31, 2017 - N°20170246150

A method and solution for perioperatively inhibiting a variety of pain and inflammation processes during arthroscopic procedures. The solution preferably includes a vasoconstrictor that demonstrates substantial agonist activity at alpha adrenergic receptors and that is selected for peripheral (local) vasoconstriction and one or more additional pain and inflammation inhibitory agents at dilute concentration in a physiologic carrier, such as saline ...
Vasocon Patent Pack
Download + patent application PDFs
Vasocon Patent Applications
Download + Vasocon-related PDFs
For professional research & prior art discovery
inventor
  • + full patent PDF documents of Vasocon-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Magnetic thermal control
Inventure Holdings
August 24, 2017 - N°20170239080

A system for warming or cooling a mammal by affecting blood flow to a portion of the body that is warmed or cooled, the system. The system has at least one magnet having a magnetic field. The at least one magnet contacts, directly or indirectly, the body portion, a second body portion, or combinations thereof to increase blood flow, minimize ...
Tumescent drug delivery
Inventure Holdings
August 03, 2017 - N°20170216198

A method of subcutaneous delivery of a drug or a therapeutic agent to a subject comprising administering to said subject a mass of fluid of a tumescent composition comprising: (a) the drug or the therapeutic agent; (b) a vasoconstrictor; and (c) a pharmaceutically acceptable carrier, wherein a relatively large total amount of the drug is isolated from systemic circulation in ...
Novel hemostatic patch and uses thereof
Inventure Holdings
July 06, 2017 - N°20170189573

Disclosed herein is a novel hemostatic patch that may be used to control and/or arrest bleeding in patients. The patch offers an effective but also minimally invasive way to control and/or arrest bleeding in a patient. The patch comprises a mucoadhesive and a compound that causes vasoconstriction. In a preferred aspect, the patch comprises chitosan and neuropeptide y. ...
Vasocon Patent Pack
Download + patent application PDFs
Vasocon Patent Applications
Download + Vasocon-related PDFs
For professional research & prior art discovery
inventor
  • + full patent PDF documents of Vasocon-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Treatment systems processes and devices addressing cerebral vasospasm/vasoconstriction
Omeros Corporation
March 30, 2017 - N°20170086992

Endovascular treatment of, for example, delayed cerebral vasospasm involves the placing of a microcatheter in the affected vessels followed by the teachings of the instant disclosure, which is clinically improved with comparison to slow infusion of a vasodilating compound. Systems, processes and self-expanding designed stents and stent-like members are featured and highlighted. The stents and stent-like members being retrieved, nothing ...
Control of blood vessel physiology to treat skin disorders
Biochemics, Inc.
August 18, 2016 - N°20160235846

In a method for treating an affected skin region of a patient having a skin disorder, a vasodilation composition is applied to an affected skin region of a patient, the affected skin region exhibiting a skin disorder characterized by at least one abnormal blood vessel, and the affected skin region is then treated so as to non-invasively disrupt tissue architecture, ...
Arthroscopic irrigation solution and method for peripheral vasoconstriction and inhibition of pain and inflammation
Biochemics, Inc.
June 30, 2016 - N°20160184272

A method and solution for perioperatively inhibiting a variety of pain and inflammation processes during arthroscopic procedures. The solution preferably includes a vasoconstrictor that demonstrates substantial agonist activity at alpha adrenergic receptors and that is selected for peripheral (local) vasoconstriction and one or more additional pain and inflammation inhibitory agents at dilute concentration in a physiologic carrier, such as saline ...
Novel hemostatic patch and uses thereof
Biochemics, Inc.
June 02, 2016 - N°20160151532

Disclosed herein is a novel hemostatic patch that may be used to control and/or arrest bleeding in patients. The patch offers an effective but also minimally invasive way to control and/or arrest bleeding in a patient. The patch comprises a mucoadhesive and a compound that causes vasoconstriction. In a preferred aspect, the patch comprises chitosan and neuropeptide y. ...
Non-flushing niacin analogues, and methods of use thereof
Trustees Of Tufts College
June 02, 2016 - N°20160151343

One aspect of the present invention relates to substituted pyridines and pharmaceutically acceptable salts thereof that are active against a range of mammalian maladies. Another aspect of the invention relates to a pharmaceutical composition, comprising a compound of the present invention or a pharmaceutically acceptable salt thereof; and a pharmaceutically acceptable excipient. The present invention also relates to methods of ...
Methods for treating pulmonary hypertension
The Medicines Company
May 19, 2016 - N°20160136196

The present invention relates to methods for treating or preventing pulmonary hypertension, reducing mortality in a subject experiencing pulmonary hypertension, or inhibiting adp-mediated vasoconstriction of pulmonary arteries in a subject, comprising administering to the subject an effective amount of a pharmaceutical composition comprising a reversible p2y12 receptor antagonist. Also provided are related medicaments, pharmaceutical compositions, and methods for preparing ...
Composition and method for treating nosebleeds
Binyarco, Llc
May 12, 2016 - N°20160128970

A composition and method for treating nosebleed, that is, epistaxis. The composition comprises bismuth subgallate and a vasoconstriction agent, preferably oxymetazoline. The composition is preferably a paste administered intranasally.
Vasocon Patent Pack
Download + patent application PDFs
Vasocon Patent Applications
Download + Vasocon-related PDFs
For professional research & prior art discovery
inventor
  • + full patent PDF documents of Vasocon-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Therapeutic suit
Omeros Corporation
April 28, 2016 - N°20160113812

The therapeutic suit reliefs joint pain by applying heat or cold relief to one or all joints of the body and bringing healing to joints by vasoconstriction, centralizing oxygenated blood around the joints during cold therapy treatment.
Method and system for providing an early risk recognition monitoring
Medieta Oy
March 24, 2016 - N°20160081628

A system for providing an early risk recognition monitoring by measurement of a peripheral tissue perfusion of a patient instead of clinically significant changes in systemic blood pressure and/or blood flow comprises a wristband device for gathering measurement data of the patient. The device measures a first temperature (t1) of the patient at the first wrist (or distal antebrachium) ...
Arthroscopic irrigation solution and method for peripheral vasoconstriction and inhibition of pain and inflammation
Omeros Corporation
March 10, 2016 - N°20160067219

A method and solution for perioperatively inhibiting a variety of pain and inflammation processes during arthroscopic procedures. The solution preferably includes a vasoconstrictor that exhibits alpha-adrenergic activity and one or more additional pain and inflammation inhibitory agents at dilute concentration in a physiologic carrier, such as saline or lactated ringer's solution. The solution is applied by continuous irrigation of a ...
Salvinorin compositions and uses thereof
The Trustees Of The University Of Pennsylvania
December 24, 2015 - N°20150366840

The invention relates to salvinorin compositions and uses thereof. Specifically, the invention relates to administering salvinorin compositions to treat diseases and disorders associated with vasoconstriction, vaso-occlusion, or disruption of blood flow and autoregulation. For example, salvinorin compositions may be administered to subjects with cardiac arrest, subarachnoid hemorrhage, stroke, cerebral vascular spasm, cerebral hypoxia/ischemia, cerebral artery occlusion, or any condition ...
Composition for prevention of vasoactivity in the treatment of blood loss and anemia
The Trustees Of The University Of Pennsylvania
October 15, 2015 - N°20150290213

The present invention relates to the prevention of cardiovascular and central nervous system side effects in mammals who receive transfusions of hemoglobin based oxygen carriers (hboc) or stored blood products containing a concentration of hemoglobin sufficient to induce vasoconstriction, by adding a vasoactivity reducing effective amount of one or more phosphodiesterase inhibitors in combination with a calcium channel blocker and/...
Cyanocobalamin, methylcobalamin, and/or adenosylcobalamin to help maintain a pain-free head and pain-free body and ...
The Trustees Of The University Of Pennsylvania
July 02, 2015 - N°20150182548

The current invention discloses novel approaches to help individuals defend against headaches and body pains with orally-delivered cyanocobalamin, methylcobalamin, adenosylcobalamin, and combinations thereof. Original clinical research conducted by the inventor on almost 2,000 humans yielded surprising and unexpected results showing differences in the frequency and severity of pains in the head and the body favoring cyanocobalamin patients over placebo. In one ...
No/nitrogen gaseous mixture with a high no content for the treatment of severe hypoxemic ...
Air Liquidee Sante (international)
May 07, 2015 - N°20150125552

The invention concerns a gaseous medicine comprising a mixture of nitrogen monoxide (no) and nitrogen (n2) for use by inhalation for the treatment of hypoxemic respiratory failure linked to pulmonary vasoconstriction in humans, said gaseous mixture containing between 1200 and 4500 ppm by volume (ppmv) of nitrogen monoxide (no) and said hypoxemic respiratory failure being chosen from acute respiratory distress syndrome (ards) ...
Compositions and methods for modulation of vascular structure and/or function
Marine Polymer Technologies, Inc.
April 30, 2015 - N°20150118281

The present invention relates to compositions comprising semi-crystalline β-1-4-n-acetylglucosamine polymers (p-glcnac) and methods utilizing such polymers modulation of vascular structure and/or function. The compositions and methods disclosed are useful for stimulating, in a p-glcnac concentration-dependent manner, endothelin-1 release, vasoconstriction, and/or reduction in blood flow out of a breached vessel, as well as for contributing ...
Loading